-The Indian Express Prime Minister Narendra Modi wants doctors to prescribe Generic Medicines over branded ones. KAUNAIN SHERIFF M answers key questions on the pricing of drugs and beyond. * What exactly has Prime Minister Narendra Modi said on generic drugs? Speaking in Surat on April 17, the Prime Minister referred to the Pradhan Mantri Bharatiya Janaushadhi Pariyojana (PMBJP), which aims to provide cheaper medical drugs to the people. “In the coming days,...
More »SEARCH RESULT
Total Matching Records found : 232
Validation of India's drug patent policy -Latha Jishnu
-Down to Earth A high level UN panel on Access to Medicines wants members to make full use of TRIPS flexibilities to protect public health If ever India needed a clear endorsement of its laws on intellectual property rights (IPRs) and their application in meeting public health priorities, it has come from the highest quarters. The report of the UN Secretary General’s High Level Panel (HLP) on Access to Medicines has, directly...
More »Indian generics bringing down global price of hepatitis C drugs, finds WHO -Himani Chandna
-Hindustan Times India’s generic drug manufacturers have flooded the market with cheaper medicines to treat hepatitis C after Gilead Sciences Inc’s patent application was rejected in January 2015. Thanks to domestic drugmakers, the world is looking to India to reduce the price of hepatitis C drug further. “By scaling up the production of Generic Medicines, India is playing a pivotal role globally in reducing the prices of medicines for hepatitis C,” said Henk...
More »Leveraging primary care -Poonam Khetrapal Singh
-The Hindu Health-care workers at the primary level must be given the knowledge and skills to provide NCD and associated risk factor care. Noncommunicable diseases (NCD) such as diabetes, respiratory diseases, cancer and heart diseases are taking a severe toll on public health across the WHO South-East Asia Region. Approximately 8.5 million lives, many of them premature, are lost each year due to NCDs, making them the region’s leading cause of death...
More »A disaster in the making -A Rangarajan
-Frontline Medecins Sans Frontieres warns that the free or regional trade agreements that are being negotiated, which seek to strengthen current patent regimes, are a potential threat to the developing world’s access to life-saving drugs, which it sources mostly from India. WHEN NELSON MANDELA’S GOVERNMENT passed the Medicines and Related Substances Control Act in 1997 to make medicines more accessible to the poor, 39 big pharmaceutical companies filed law suits in...
More »
